These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 411841)

  • 41. [Clinical experience with sustained release cephalexin (X-6437) (author's transl)].
    Kato R; Asano Y; Tsuzuki K; Iwayama S; Ito S
    Jpn J Antibiot; 1977 Nov; 30(11):888-92. PubMed ID: 592489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cephaloridine in acute ENT infections.
    Kameswaran S; Lakshminarayana N
    J Indian Med Assoc; 1973 Feb; 60(4):127-9. PubMed ID: 4721364
    [No Abstract]   [Full Text] [Related]  

  • 43. A trial comparing cefaclor with co-trimoxazole in the treatment of acute otitis media.
    Feldman W; Richardson H; Rennie B; Dawson P
    Arch Dis Child; 1982 Aug; 57(8):594-6. PubMed ID: 7051985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical experience with S-6436 in acute pyelonephritis (author's transl)].
    Washida H; Ueda K; Watanabe H
    Jpn J Antibiot; 1977 Oct; 30(10):802-5. PubMed ID: 592482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Co-tetroxazin (Tibirox) and doxycycline (Vibramycin) in treatment of upper respiratory tract infections: a double-blind study].
    Podvinec M
    Ther Umsch; 1982 Oct; 39(10):815-20. PubMed ID: 6760445
    [No Abstract]   [Full Text] [Related]  

  • 46. Cephalexin monohydrate suspension. Treatment of otitis media.
    McLinn SE; Daly JF; Jones JE
    JAMA; 1975 Oct; 234(2):171-3. PubMed ID: 240948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fundamental and clinical studies of sustained release cephalexin (L-Keflex) in the field of oral surgery (author's transl)].
    Morihana T; Ueda K; Muraoka M; Tsushima T; Kodama M; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1980 Apr; 33(4):514-21. PubMed ID: 6997536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical studies on serum and intra-tonsillar concentrations of ciclacillin (Vasticillin 'Takeda') and ampicillin (Solcillin 'Takeda') (author's transl)].
    Matsumoto K
    Jpn J Antibiot; 1979 Nov; 32(11):1196-202. PubMed ID: 513302
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical evaluation of cephalexin (Lilly) in oto-laryngological infections by a double blind method].
    Sawaki S
    Saishin Igaku; 1970 Jul; 25(7):1556-62. PubMed ID: 4916002
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antibiotic therapy - a critical review (author's transl)].
    Daschner F
    HNO; 1979 Jun; 27(6):181-4. PubMed ID: 457463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of S-6437, sustained release cephalexin, in pediatrics (author's transl)].
    Sato H; Fujii N; Shinnou K; Kojima S; Hirama Y
    Jpn J Antibiot; 1977 Sep; 30(9):684-90. PubMed ID: 916189
    [No Abstract]   [Full Text] [Related]  

  • 52. Cefadroxil in the treatment of acute otitis media in children.
    Puhakka H; Virolainen E; Eskola J; Holm S
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():99-103. PubMed ID: 7142101
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cephalexin and penicillin in the treatment of group A beta-hemolytic streptococcal throat infections.
    Disney FA; Dillon H; Blumer JL; Dudding BA; McLinn SE; Nelson DB; Selbst SM
    Am J Dis Child; 1992 Nov; 146(11):1324-7. PubMed ID: 1415072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Laboratory and clinical studies on clindamycin-2-palmitate in otorhinolaryngologic field (author's transl)].
    Takasu T; Baba S; Mamiya T; Hondo J; Wada K
    Jpn J Antibiot; 1973 Aug; 26(4):400-3. PubMed ID: 4542677
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical studies on S-6436 (author's transl)].
    Nakagawa K; Koyama M; Hashimoto Y
    Kansenshogaku Zasshi; 1977 Jun; 51(6):312-6. PubMed ID: 411843
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cephalexin preparation with prolonged activity (author's transl)].
    Maekawa H; Takagishi Y; Iwamoto K; Doi Y; Ogura T
    Jpn J Antibiot; 1977 Aug; 30(8):631-8. PubMed ID: 909151
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical results with cephalexin (Syncl "Toyo") for bacterial pneumonia (author's transl)].
    Yamasaku F; Aoki S; Seki G; Ito B; Kainuma T
    Jpn J Antibiot; 1974 Oct; 27(5):637-42. PubMed ID: 4455958
    [No Abstract]   [Full Text] [Related]  

  • 59. Cefixime: clinical trial against otitis media and tonsillitis.
    Scott HV; Pannowitz D; Ketelbey JW
    N Z Med J; 1990 Jan; 103(882):25-6. PubMed ID: 2406651
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical experience with S-6436 in patients with urinary tract infections (author's transl)].
    Urata H; Komeda K; Tochigi H; Morishita F; Horiuchi E
    Jpn J Antibiot; 1977 Oct; 30(10):829-34. PubMed ID: 338939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.